NotesFAQContact Us
Collection
Advanced
Search Tips
Laws, Policies, & Programs
No Child Left Behind Act 20011
What Works Clearinghouse Rating
Showing 481 to 495 of 909 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Barrett, James E. – Journal of the Experimental Analysis of Behavior, 2006
Peter B. Dews played a significant role in shaping the distinctive characteristics and defining the underlying principles of the discipline of behavioral pharmacology. His early and sophisticated use of schedules of reinforcement in the 1950s, incorporated from research in the experimental analysis of behavior and integrated into the discipline of…
Descriptors: Behavior Problems, Discipline, Pharmacology, Role
Peer reviewed Peer reviewed
Direct linkDirect link
Kontos, Nicholas; Querques, John; Freudenreich, Oliver – Academic Psychiatry, 2006
Objective: The psychopharmacologist designation currently pervades and heavily influences the practice, perception, and teaching of clinical psychiatry. The authors hope to make a case and provide the raw material for informed discussion of this role during psychiatric residency training. Method: A definition for the psychopharmacologist is…
Descriptors: Psychiatry, Patients, Teaching Methods, Pharmacology
Peer reviewed Peer reviewed
Direct linkDirect link
Spencer, Thomas J.; Faraone, Stephen V.; Biederman, Joseph; Lerner, Marc; Cooper, Kimberly M.; Zimmerman, Brenda – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To investigate whether prolonged therapy with a long-acting stimulant affects growth in children with attention-deficit/hyperactivity disorder (ADHD). Method: One hundred seventy-eight children ages 6 to 13 years received OROS methylphenidate (OROS MPH, CONCERTA) for at least 21 months. Height and weight were measured monthly during the…
Descriptors: Body Height, Body Weight, Drug Therapy, Stimulants
Peer reviewed Peer reviewed
Direct linkDirect link
McGough, James; McCracken, James; Swanson, James; Riddle, Mark; Kollins, Scott; Greenhill, Laurence; Abikoff, Howard; Davies, Mark; Chuang, Shirley; Wigal, Tim; Wigal, Sharon; Posner, Kelly; Skrobala, Anne; Kastelic, Elizabeth; Ghuman, Jaswinder; Cunningham, Charles; Shigawa, Sharon; Moyzis, Robert; Vitiello, Benedetto – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: The authors explored genetic moderators of symptom reduction and side effects in methylphenidate-treated preschool-age children diagnosed with attention-deficit/hyperactivity disorder (ADHD). Method: DNA was isolated from 81 subjects in a double-blind, placebo-controlled, crossover methylphenidate titration. Parents and teachers…
Descriptors: Hyperactivity, Genetics, Attention Deficit Disorders, Drug Therapy
Brick, John – 1990
Marijuana or Cannabis is a weed which grows in many different parts of the world. The plant may be altered into different forms to allow various forms of ingestion. Although marijuana's psychoactive properties have been known for almost 5,000 years, the plant first attracted public attention in the United States during the first half of this…
Descriptors: Drug Abuse, Drug Use Testing, Etiology, Illegal Drug Use
Peer reviewed Peer reviewed
Werry, John S. – Journal of Child Psychology and Psychiatry and Allied Disciplines, 1981
Reviews literature pertinent to studying the effects of drugs upon children's learning and cognitive function. The author concludes such research is in its infancy. He recommends further research focus upon whether drugs enhance the acquisition of new academic skills and upon assessment of the benefits versus side effects of such drug use.…
Descriptors: Children, Cognitive Ability, Drug Therapy, Learning
Mergener, Michael A. – Mobius: A Journal for Continuing Education Professionals in Health Sciences, 1981
This study compares the scores optometrists obtained on a pharmacology examination with years since licensure and type of continuing education participation preceding the examination. Recent licensees scored better than those licensed before 1953. Continuing education activity also promoted better scores. (CT)
Descriptors: Continuing Education, Optometrists, Pharmacology, Professional Continuing Education
Peer reviewed Peer reviewed
Cates, Lindley A. – American Journal of Pharmaceutical Education, 1981
A method of estimating the solubilities of drugs in water is reported that is based on a principle applied in quantitative structure-activity relationships. This procedure involves correlation of partition coefficient values using the octanol/water system and aqueous solubility. (Author/MLW)
Descriptors: Chemical Reactions, Higher Education, Laboratory Experiments, Laboratory Procedures
Peer reviewed Peer reviewed
Edwards, David J. – American Journal of Pharmaceutical Education, 1990
A lecture given in courses in applied pharmacokinetics at Wayne State University, Michigan, is presented. The definition of bioavailability is reviewed along with methods of calculation, bioequivalence, criteria for establishing bioequivalence of a new product, essentials of a bioequivalence study, and the relationship between bioequivalence and…
Descriptors: Biomedicine, Comparative Analysis, Drug Therapy, Higher Education
Peer reviewed Peer reviewed
Block, Lawrence H. – American Journal of Pharmaceutical Education, 1990
The emergence of bioactive peptides and proteins as new drug species poses formidable problems for the pharmaceutical scientist. Implications for revision or change in undergraduate and graduate pharmaceutics curricula derive from the biopharmaceutical, pharmacokinetic, and physiochemical aspects of the new drug species, which differ from…
Descriptors: Biomedicine, Chemistry, Curriculum Development, Higher Education
Peer reviewed Peer reviewed
Aman, Michael G. – Australia and New Zealand Journal of Developmental Disabilities, 1991
This paper identifies and evaluates emerging developments in the behavioral pharmacotherapy of people with developmental disabilities, including such medications as the opiate antagonists, fenfluramine, beta adrenergic blockers, buspirone, antipsychotics, amantadine hydrochloride, and antilibidinal drugs. The need for more well-designed drug…
Descriptors: Behavior Change, Behavior Problems, Developmental Disabilities, Drug Therapy
Peer reviewed Peer reviewed
Hollon, Steven D.; And Others – Journal of Consulting and Clinical Psychology, 1991
Reviews use of cognitive therapy (CT) for depression compared to use of tricyclic pharmacotherapy in nonbipolar outpatients. Suggests that CT may be roughly comparable in treatment of the acute episode, combined CT-pharmacotherapy does not appear to be clearly superior to either modality, and CT treatment during the acute episode may reduce the…
Descriptors: Cognitive Restructuring, Depression (Psychology), Drug Therapy, Outcomes of Treatment
Peer reviewed Peer reviewed
Matson, Johnny L.; Bamburg, Jay W.; Mayville, Erik A.; Pinkston, Jim; Bielecki, Joanne; Kuhn, David; Smalls, Yemonja; Logan, James R. – Research in Developmental Disabilities, 2000
Review of the literature on psychopharmacology and mental retardation from 1990-1999 found most studies had major methodological flaws. Also, most drug administrations were not based in science, were not evaluated appropriately, and generally did not follow best practices for treatment of persons with mental retardation. A table lists the studies…
Descriptors: Drug Therapy, Medical Services, Mental Retardation, Pharmacology
Peer reviewed Peer reviewed
James, Susan Hackbarth; Nims, Donald R. – School Counselor, 1996
Although school counselors are increasingly involved in administering medications to students with emotional, conduct, and behavioral problems, few counselors have training in psychopharmacology. Gives a brief history of psychopharmacological interventions, and describes usage and side effects of drugs for psychosis, depression, anxiety, and…
Descriptors: Adolescents, Children, Drug Therapy, Higher Education
Peer reviewed Peer reviewed
March, John; Kratochvil, Christopher; Clarke, Gregory; Beardslee, William; Derivan, Albert; Emslie, Graham; Green, Evelyn P.; Heiligenstein, John; Hinshaw, Stephen; Hoagwood, Kimberly; Jensen, Peter; Lavori, Philip; Leonard, Henrietta; McNulty, James; Michaels, M. Alex; Mossholder, Andrew; Osher, Trina; Petti, Theodore; Prentice, Ernest; Vitiello, Benedetto; Wells, Karen – Journal of the American Academy of Child and Adolescent Psychiatry, 2004
Objective: The use of placebo in the pediatric age group has come under increasing scrutiny. At the 2002 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, the Academy's Workgroup on Research conducted a research forum. The purpose was to identify challenges and their solutions regarding the use of placebo in randomized…
Descriptors: Research Design, Psychiatry, Pharmacology, Industry
Pages: 1  |  ...  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  ...  |  61